Cited by 124Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsCognitive Abilities and Testing

Effects of APOE ‐ε4 allele load on brain morphology in a cohort of middle‐aged healthy individuals with enriched genetic risk for Alzheimer's disease

Open access
Cacciaglia, Raffaele, Molinuevo, José Luis, Falcón, Carles, Brugulat‐Serrat, Anna, Sánchez‐Benavides, Gonzalo, Gramunt, Nina, Esteller, Manel, Morán, Sebastián +4 more·2018·Alzheimer's & Dementia

Abstract

Introduction: Apolipoprotein E ( APOE )‐ε4 is the major genetic risk factor for Alzheimer's disease. However, the dose‐dependent impact of this allele on brain morphology of healthy individuals remains unclear. Methods: We analyzed gray matter volumes (GMvs) in a sample of 533 healthy middle‐aged individuals with a substantial representation of ε4‐carriers (207 heterozygotes and 65 homozygotes). Results: We found APOE ‐ε4 additive GMv reductions in the right hippocampus, caudate, precentral gyrus, and cerebellar crus. In these regions, the APOE genotype interacted with age, with homozygotes displaying lower GMv after the fifth decade of life. APOE ‐ε4 was also associated to greater GMv in the right thalamus, left occipital gyrus, and right frontal cortex. Discussion: Our data indicate that APOE ‐ε4 exerts additive effects on GMv in regions relevant for Alzheimer's disease pathophysiology already in healthy individuals. These findings elucidate the mechanisms underlying the increased Alzheimer's disease risk in ε4‐carriers, suggesting a dose‐dependent disease vulnerability on the brain structure level.

Integrity signals

Registry

Crossref · 10.1016/j.jalz.2018.01.016

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Increased thalamic volume and hypermetabolism with amyloid pathology have been reported among APOE4 carriers.

    “The role of thalamic structure and function in AD appears complex and perhaps nonlinear, as thalamic atrophy in MCI [48] and hypometabolism in APOE4 carriers [49] have been observed, whereas others have reported increased thalamic volume [50] and hypermetabolism with amyloid pathology [51] among APOE4 carriers.”

The citation lists haven’t been fetched yet

References 57 · Cited by 124

Authors
Cacciaglia, R., Molinuevo, J. L., Falcón, C., Brugulat‐Serrat, A., Sánchez‐Benavides, G., Gramunt, N., Esteller, M., Morán, S., Minguillón, C., Fauria, K., Gispert, J. D., & study, F. T. A.
Affiliations
  • Pasqual Maragall Foundation (ES)
  • Barcelonabeta Brain Research Center Pasqual Maragall Foundation Barcelona Catalonia Spain
  • Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (ES)
  • Institució Catalana de Recerca i Estudis Avançats (ES)
  • Institut d'Investigació Biomédica de Bellvitge (ES)
Corresponding author
Gispert, Juan Domingo
Venue
Alzheimer's & Dementia
Publisher
Wiley
Published
2018-03-28
Volume
14
Issue
7
Pages
902-912
ISSN
  • 1552-5260 (ISSN-L)
  • 1552-5279
OpenAlex
W2795068887
Cited by
124
References
57
Citations by year
2026: 5 · 2025: 7 · 2024: 14 · 2023: 17 · 2022: 14 · 2021: 23 · 2020: 22 · 2019: 14 · 2018: 7 · 2017: 1
FWCI
12.95
Type
journal article
Language
en
Open access
Locations
  • Alzheimer s & Dementia (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (submittedVersion, cc-by-nc-nd)
Funders
“la Caixa” Foundation (PI12/00326)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Cognitive Abilities and Testing
Keywords
APOE ε4, apolipoprotein E
MeSH terms
Aged, Aging, Alleles, Alzheimer Disease, Cerebral Cortex, Female, Genotype, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Neuropsychological Tests, Risk Factors, Cohort Studies, Apolipoprotein E4, Healthy Volunteers, Gray Matter

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review